SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (3588)4/26/2001 1:09:02 AM
From: scaram(o)uche  Respond to of 52153
 
BM:

Can't really update my post/thoughts, but an Arena collaboration is a very good sign.

Since both Glass and Andren are sitting on the Board, I assume that all is well on the Arena "further dilution" front.

The Biacore money has allowed for a transformation. Different creature than we were evaluating. Webb still seems to be providing insights, and I presume that the GPCR effort has legs. That would spell leverage.

Looks like something will emerge from the fog soon? Hope so.

Rick



To: BulbaMan who wrote (3588)4/26/2001 9:19:37 AM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
BulbaMan,

I don't think your calculation method is correct. See my earlier post on this:

Message 15119733

Anyhow, at this point those historical valuations are pretty irrelevant - the key is how Axiom is doing now.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News